Support Alert

Drug Safety Update: Pseudoephedrine and ephedrine

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update highlighting that sales restrictions introduced in 2008 continue to be successful in managing the risk of misuse of pseudoephedrine and ephedrine. The update includes a 2017 review of the impact of restrictions.

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society

Return To Top